The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, JT, COST, CWH, OZK, NKTR and AQUA
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Apogee Enterprises, Inc. (NASDAQGS: APOG) Class Period: June 28, 2018 to September 17, 2018 Lead Plaintiff Deadline: January 4, 2019
The lawsuit alleges that Apogee Enterprises, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Apogee lacked the required labor force in place to ramp-up its production; (ii) Apogee was unable to hire, train and retain new employees; (iii) Apogee’s productivity and margins would be negatively impacted; and (iv) as a result of the foregoing, Defendants’ statements about the Company’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
Get additional information about the APOG lawsuit: http://www.kleinstocklaw.com/pslra-1/apogee-enterprises-inc-loss-submission-form?wire=3
Jianpu Technology Inc. (NYSE: JT) Class Period: Pursuant and/or traceable to the initial public offering on or about November 16, 2017 Lead Plaintiff Deadline: December 24, 2018
The complaint alleges that the Company’s IPO offering materials contained inaccurate statements of material fact and/or omitted material information required to be disclosed in order to make such statements not misleading, including failure to disclose that the China Banking Regulatory Commission and three other Chinese regulators had issued rules in 2016 requiring peer-to-peer lending companies to appoint qualified banking institutions as custodians and disclose their use of deposits. On November 21, 2017, news outlets reported that China’s Financial Stability and Development Committee (“FSDC”) had issued an urgent notice to provincial governments urging them to suspend regulatory approval of new internet micro-loan companies. Following this news, Jianpu’s shares fell over 38% in three days and closed at $4.90 per share on November 24, 2017.
Get additional information about the JT lawsuit: http://www.kleinstocklaw.com/pslra-1/jianpu-technology-inc-loss-submission-form?wire=3
Costco Wholesale Corporation (NASDAQGS: COST) Class Period: June 6, 2018 to October 25, 2018 Lead Plaintiff Deadline: January 7, 2019
The lawsuit alleges Costco Wholesale Corporation made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) Costco lacked effective internal control over financial reporting; (ii) as a result of the foregoing, Defendants’ statements about Costco’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On October 4, 2018, Costco announces that “in its upcoming fiscal 2018 Annual Report on Form 10-K, it expects to report a material weakness in internal control. The weakness relates to general information technology controls in the areas of user access and program change-management over certain information technology systems that support the Company’s financial reporting processes. The access issues relate to the extent of privileges afforded users authorized to access company systems.” Following this news, shares of Costco fell from a close of $231.68 on October 4, 2018, to a close of $218.82 the following day.
Get additional information about the COST lawsuit: http://www.kleinstocklaw.com/pslra-1/costco-wholesale-corporation-loss-submission-form?wire=3
Camping World Holdings, Inc. (NYSE: CWH) Class Period: March 8, 2017 to August 7, 2018 Lead Plaintiff Deadline: December 18, 2018
Camping World Holdings, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s disclosure controls and controls over financial reporting suffered from a host of material weaknesses; (2) the Company’s historical financial results had been materially misstated; (3) the Gander stores had encountered integration setbacks, adversely impacting the Company’s earnings growth and profit margins; and (4) the Company’s core RV business was experiencing decelerating growth as the Company lagged industry trends and was losing market share to competitors.
Get additional information about the CWH lawsuit: http://www.kleinstocklaw.com/pslra-1/camping-world-holdings-inc-loss-submission-form?wire=3
Bank OZK (NASDAQGS: OZK) Class Period: February 19, 2016 to October 18, 2018 Lead Plaintiff Deadline: December 26, 2018
Throughout the class period, Bank OZK allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls to assess credit risk; (2) as a result, certain of the Company’s loans posed an increased risk of loss; (3) certain substandard loans were reasonably likely to lead to charge-offs; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On October 18, 2018, the Company reported that it had “incurred combined charge-offs of $45.5 million on two Real Estate Specialties Group credits” that had previously been classified as substandard. On this news, the Company’s share price fell $9.33 per share to close at $25.52 per share on October 19, 2018.
Get additional information about the OZK lawsuit: http://www.kleinstocklaw.com/pslra-1/bank-ozk-loss-submission-form?wire=3
Nektar Therapeutics (NASDAQ: NKTR) Class Period: November 11, 2017 to October 2, 2018 Lead Plaintiff Deadline: December 31, 2018
The complaint alleges that throughout the class period Nektar Therapeutics made materially false and/or misleading statements and/or failed to disclose that: (1) prior studies which attempted to pegylate IL-2 failed; (2) the extended half-life of the Company’s lead I-O candidate, NKTR-214, was unlikely to result in efficacy and created additional high-dosing safety concerns; (3) NKTR-214 was less effective than IL-2 alone; (4) the combination of NKTR-214 with nivolumab has yet to demonstrate significant positive results; and (5) as a result, Nektar’s public statements as set forth above were materially false and misleading at all relevant times.
Get additional information about the NKTR lawsuit: http://www.kleinstocklaw.com/pslra-1/nektar-therapeutics-loss-submission-form?wire=3
Evoqua Water Technologies Corp. (NYSE: AQUA) Class Period: November 6, 2017 to October 30, 2018 Lead Plaintiff Deadline: January 7, 2019
The lawsuit alleges that Evoqua Water Technologies Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) Evoqua failed to successfully integrate its prior acquisitions; (2) Evoqua was experiencing supply chain disruptions influenced by tariffs and an extended delay on a large aquatics project; and (3) as a result, Evoqua’s public statements were materially false and misleading at all relevant times.
Get additional information about the AQUA lawsuit: http://www.kleinstocklaw.com/pslra-1/evoqua-water-technologies-corp-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118 email@example.com Telephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.com